Oncopeptides AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	82.26	178.54	173.41	344.52	362.19
Short-Term Investments	-	-	0.03	0.35	2.11
Cash & Short-Term Investments	82.26	178.54	173.44	344.86	364.3
Cash Growth	-53.93%	2.94%	-49.71%	-5.33%	-57.27%
Accounts Receivable	26.66	7.29	2.19	0.67	11.87
Other Receivables	-	6.24	15.68	16.25	24.01
Receivables	26.66	13.53	17.87	16.92	35.89
Inventory	8.24	4.37	2.43	-	-
Prepaid Expenses	-	6.19	5.43	1.71	7.42
Other Current Assets	-	9.96	3.73	0.54	4.76
Total Current Assets	117.16	217.08	202.9	364.03	412.37
Property, Plant & Equipment	17.68	27.11	34.63	20.44	24.74
Other Intangible Assets	-	-	-	-	1.41
Other Long-Term Assets	-	-0	0.85	0.85	0.85
Total Assets	134.84	244.19	238.38	385.32	439.38
Accounts Payable	0.7	18.17	15.03	28.22	35.7
Accrued Expenses	-	15.12	20.38	17.24	36.61
Current Portion of Leases	-	7.27	5.13	6	10.99
Current Income Taxes Payable	-	1.73	0.58	0.3	0.05
Current Unearned Revenue	-	0.07	0.5	-	-
Other Current Liabilities	43.8	4.66	3.32	33.91	141.94
Total Current Liabilities	44.5	51.36	44.93	85.67	225.29
Long-Term Debt	126.68	121.89	106.49	-	-
Long-Term Leases	22.55	12.55	19.67	-	3.21
Other Long-Term Liabilities	-	4.11	10.51	5.36	0.01
Total Liabilities	193.73	189.91	181.6	91.03	228.51
Common Stock	30.3	23.91	10.51	10.48	8.37
Additional Paid-In Capital	-	5,684	5,414	5,403	4,982
Retained Earnings	-	-5,651	-5,366	-5,116	-4,778
Comprehensive Income & Other	-89.19	-2.84	-2.2	-2.3	-0.92
Shareholders' Equity	-58.89	54.29	56.78	294.29	210.87
Total Liabilities & Equity	134.84	244.19	238.38	385.32	439.38
Total Debt	149.23	141.72	131.29	6	14.19
Net Cash (Debt)	-66.97	36.82	42.15	338.86	350.11
Net Cash Growth	-	-12.65%	-87.56%	-3.21%	-57.98%
Net Cash Per Share	-0.07	0.22	0.47	4.12	4.65
Filing Date Shares Outstanding	272.71	215.19	94.6	94.31	75.29
Total Common Shares Outstanding	272.71	215.19	94.6	94.31	75.29
Working Capital	72.66	165.73	157.97	278.36	187.08
Book Value Per Share	-0.22	0.25	0.60	3.12	2.80
Tangible Book Value	-58.89	54.29	56.78	294.29	209.46
Tangible Book Value Per Share	-0.22	0.25	0.60	3.12	2.78
Machinery	-	16.46	16.1	15.99	14.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.